Aquinox Pharma (AQXP) to Present Positive Data from LEADERSHIP Phase 2 at 2015 ESSIC Meeting
Tweet Send to a Friend
Aquinox Pharma (NASDAQ: AQXP) announced that an abstract from the LEADERSHIP Phase 2 clinical trial with AQX-1125 in bladder pain ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
